Coverage guide
Medicare GLP-1 Bridge: The $50/Month Copay Explained
The Medicare GLP-1 Bridge is a CMS demonstration that changes how some enrollees pay for covered GLP-1 medications used for specific indications. In the demonstration, eligible participants pay a flat $50 per month per covered prescription instead of ordinary Part D cost-sharing.\n\nProducts currently in the Bridge program are semaglutide (Wegovy) and tirzepatide (Zepbound KwikPen) for eligible indications. Coverage still depends on meeting the demonstration's eligibility criteria, a prescriber willing to participate, and pharmacy handling - the Bridge does not make a drug universally available.\n\nVerify before you plan around it: (1) that your diagnosis fits a Bridge-covered indication, (2) that your prescriber participates, (3) which pharmacy supplies the Bridge-priced prescription, and (4) the current demonstration period dates with CMS or a SHIP counselor.
What to check next
Confirm the exact medication, diagnosis, formulary tier, prior authorization requirement, step therapy status, and pharmacy network before relying on a listing.
Useful documents
Plan formularies, Evidence of Coverage documents, pharmacy directories, and written prior-authorization criteria are more reliable than verbal summaries alone.